Navigation Links
SpineSmith Partners to Present at 3rd Annual Stem Cell Summit

AUSTIN, Texas, Feb. 25 /PRNewswire/ -- SpineSmith Partners, LP, a biotech medical device company that focuses on new treatments for spinal disorders, announced today that Dr. Robert G. Johnson, MD, and Dr. Stuart Williams, PhD, are scheduled to present at the 3rd Annual Stem Cell Summit in New York City on Tuesday, Feb. 26, 2008.

Dr. Williams is Scientific Director of the Cardiovascular Innovation Institute at the University of Louisville School of Medicine. He is also the Chief Science Officer for Tissue Genesis, Inc.

Williams is recognized internationally as an expert in vascular biology and vascular tissue engineering, and is a leader in endothelial cell isolation technology. He developed and patented the technique of isolating human endothelial cells and pluripotent stem cells from fat tissue obtained through liposuctions, currently licensed by Tissue Genesis through Thomas Jefferson University.

Dr. Johnson, a San Antonio, Texas-based orthopedic surgeon is pioneering a new technology utilizing highly concentrated adult stem cells in spine surgery. With over 300 cases performed and a prospective clinical study showing positive results, Dr. Johnson believes that adult stem cells have a place in spine surgery and further applications throughout orthopedics.

Dr. Johnson has been using the new approach to treat patients since April 2006. The adult stem cells are concentrated from the patient's own bone marrow utilizing a point of care system during the spinal procedure.

"It is already well known that stem cells originating from bone marrow have the capability to form blood, nerve and bones. The goal is to help patients recover faster and, hopefully, better," said Dr. Johnson. "We have good reason to be optimistic that the stem cells will provide reliable and consistent fusion and reduce the chances that the patient will require future surgeries."

Since autologous procedures use the patient's own cells, derived from bone marrow or adipose (fat) tissue, the likelihood of rejection of a foreign tissue or synthetic substance is no longer a concern.

About SpineSmith Partners, LP

SpineSmith, LP, ( designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. We take a different approach from other companies, utilizing a collaborative approach between scientists, engineers and spine surgeons. This approach results in the development of truly innovative biological and hardware technologies for use in the treatment of patients with spinal disorders.

About the 3rd Annual Stem Cell Summit

The Annual Stem Cell Summit is organized and produced by RRY Publications and Robin Young Consulting. This year's Summit is slated to bring together investors, industry executives, practitioners and analysts to learn about the investment opportunities in the stem cell marketplace, the groundbreaking stem cell products physicians are using today and the growing market potential in terms of revenues. For additional information or to register, please visit


Keri Kimler


This release was issued through eReleases(TM). For more information, visit

SOURCE SpineSmith Partners, LP
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
2. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
3. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
4. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
5. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):